Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Not Missing Assessment Goals, But Guidance Reminds That It’s Possible
Jun 01 2020
•
By
Derrick Gingery
Guidance addresses potential for user fee goal misses and virtual advisory committee meetings. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet